Lung Cancer Research Foundation Welcomes New Members to Board of Directors
Retrieved on:
Tuesday, January 9, 2024
Hope, MHA, Legal defense fund, EGFR, MET, Research, Risk, Partner, Life, Operation, Leptomeningeal cancer, Perception, Jews, University, Lung cancer, Patient satisfaction, Tejal, Chicago metropolitan area, Metropolitan Family Services, Disease, COVID-19, Congress, Organization, Vaccine, Diagnosis, Health administration
NEW YORK, Jan. 9, 2024 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to welcome Jill Morningstar and Tejal Patel to its Board of Directors.
Key Points:
- NEW YORK, Jan. 9, 2024 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to welcome Jill Morningstar and Tejal Patel to its Board of Directors.
- Most recently, Jill chaired the LungCAN Steering Committee advocating for increased federal funding for lung cancer research.
- "Lung cancer research means everything to us, and I am excited to be joining the board of the Lung Cancer Research Foundation."
- Over the last several months, she has been involved with the Lung Cancer Research Foundation and raised over $46,000 to support leading edge cancer research through her team, Breathe Easy Fight Hard.